|
Volumn 364, Issue 7, 2011, Pages 683-684
|
Outcomes of kidney transplantation in HIV-infected recipients [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHRONIC KIDNEY DISEASE;
GRAFT RECIPIENT;
GRAFT REJECTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
KIDNEY TRANSPLANTATION;
LETTER;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
ADULT;
CD4 LYMPHOCYTE COUNT;
CHRONIC KIDNEY FAILURE;
IMMUNOLOGY;
IMMUNOSUPPRESSIVE TREATMENT;
MIDDLE AGED;
NOTE;
PATIENT SELECTION;
AREA UNDER THE CURVE;
DRUG BLOOD LEVEL;
DRUG HALF LIFE;
DRUG MONITORING;
DRUG POTENTIATION;
DRUG INTERACTION;
ADULT;
CD4 LYMPHOCYTE COUNT;
GRAFT REJECTION;
HIV INFECTIONS;
HUMANS;
IMMUNOSUPPRESSION;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
MIDDLE AGED;
PATIENT SELECTION;
AREA UNDER CURVE;
DRUG INTERACTIONS;
HIV PROTEASE INHIBITORS;
IMMUNOSUPPRESSIVE AGENTS;
TACROLIMUS;
PROTEINASE INHIBITOR;
TACROLIMUS;
HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR;
IMMUNOSUPPRESSIVE AGENT;
|
EID: 79951839899
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1014114 Document Type: Letter |
Times cited : (13)
|
References (2)
|